RANI Rani Therapeutics Holdings,...

Nasdaq ranitherapeutics.com


$ 1.67 $ 0.26 (18.98 %)    

Friday, 17-Oct-2025 16:24:53 EDT
QQQ $ 604.73 $ 6.27 (1.05 %)
DIA $ 462.18 $ 2.39 (0.52 %)
SPY $ 665.04 $ 4.85 (0.74 %)
TLT $ 91.03 $ -0.05 (-0.05 %)
GLD $ 389.86 $ -8.41 (-2.12 %)
$ 0.4709
$ 1.37
$ 1.67 x 707
$ 1.68 x 7,300
$ 1.13 - $ 2.39
$ 0.39 - $ 2.81
274,253
na
33.84M
$ 0.46
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-31-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-06-2024 03-31-2024 10-Q
7 03-20-2024 12-31-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-11-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 03-22-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-10-2022 06-30-2022 10-Q
14 05-11-2022 03-31-2022 10-Q
15 03-30-2022 12-31-2021 10-K
16 11-16-2021 09-30-2021 10-Q
17 09-13-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rani-teams-up-with-chugai-to-revolutionize-oral-drug-delivery-for-rare-diseases

Rani Therapeutics (NASDAQ: RANI) stock surged on licensing collaboration with Chugai and $60.3M private placement. RANI up 191....

Core News & Articles

Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session. The market value of their...

 rani-therapeutics-holdings-files-for-mixed-shelf-offering-of-up-to-200m

-SEC Filing

 rani-therapeutics-hldgs-q2-eps-018-beats-024-estimate

Rani Therapeutics Hldgs (NASDAQ:RANI) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION